Flavonolds In the prevention and treatment of cardiovascular diseases;Flawonoidy w prewencji i leczeniu chorób układu sercowo-naczyniowego

Polski Merkuriusz Lekarski

Volumn 32, Issue 187, 2012, Pages 50-54

  Majewska Wierzbicka, Monika ^a   Czeczot, Hanna ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Antioxidant properties; Biological activities; Cardiovascular system; Flavonoids

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; FLAVONOID; LOW DENSITY LIPOPROTEIN; VASODILATOR AGENT;

ATHEROSCLEROSIS; BLOOD VESSEL; CARDIOVASCULAR DISEASE; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; REVIEW;

ANTI-INFLAMMATORY AGENTS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; ATHEROSCLEROSIS; BLOOD VESSELS; CARDIOVASCULAR DISEASES; FLAVONOIDS; HUMANS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; VASODILATOR AGENTS;

EID: 84856934638     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Aldini G., Yeum K.J., Carini M. et al.: (-)-Epigallocatechin-(3)-gallate prevents oxidative damage in both the aqueous and lipid compartments of human plasma. Blochem. Blophys. Res. Commun., 2003; 302; 409-414. (Pubitemid 36397938)
2. Arora A., Nair M.G., Strasburg G.M.: Structure-activity relationships for antioxidant activities of series of flavonoids in a liposomal system. Free Radic. Biol. Med., 1998; 24 (9); 1355-1363. (Pubitemid 28270336)
3. Broncel M.: Przeciwmiażdżycowe działanie flawonoidów izolowanych z korzenia tarczycy bajkalskiej. Wiad. Lek., 2007; 60 (5-6); 294-297.
4. Burda S., Oleszek W.: Antioxidant and antiradical activities of flavonoids. J. Agric. Food Chem., 2001; 49; 2774-2779. (Pubitemid 32826067)
5. Czeczot H.: Biological activities of flavonoids - a review. Pol. J. Food Nutr. Sci., 2000; 50 (4); 3-13.
6. Duffy S.J., Keaney J.F., Holbrook M. et al.: Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation, 2001; 104; 151-156. (Pubitemid 32655830)
7. Fuhrman B., Aviram M.: Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr. Opin. Lipidol., 2001; 12 (1); 41-48. (Pubitemid 32121284)
8. George J., Afek A., Shaish A. et al.: 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation, 2001; 104; 1646-1650. (Pubitemid 32947528)
9. Gonzdlez-Gallego J., Sśnchez-Campos S., Tunón M.J.: Anti-inflammatory properties of dietary flavonoids. Nutr. Hosp., 2007; 22 (3); 287-293.
10. Grassi D., Desiden G., Ferri C.: Flavonoids: antioxidants against atherosclerosis. Nutrients, 2010; 2; 889-902.
11. Harborne J.B., Williams C.A.: Advances in flavonoid research since 1992. Phytochemistry, 2000; 55; 481-504.
12. Havsteen B.H.: The biochemistry and medical significance of the flavonoids. Pharmacol. Ther., 2002; 96; 2-3; 67-202. (Pubitemid 35356564)
13. Heim K.E., Tagliaferro A.R., Bobilya D.J.: Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J. Nutr. Biochem., 2002; 13 (10); 572-584. (Pubitemid 35246546)
14. Hertog M.G.L., Feskens E.J.M., Hollman P.C.H. et al.: Dietary antioxidant flavonoids and risk of coronary heart disease. The Zutphen elderly study. Lancet, 1993; 342; 1007-1011. (Pubitemid 23314801)
15. Hertog M.G.L., Feskens E.J.M., Kromhout D.: Antioxidant flavonols and coronary heart disease risk. Lancet, 1997; 349 (9053); 699. (Pubitemid 27107753)
16. Hertog M.G.L., Kromhout D., Aravanis C. et al.: Flavonoid intake and long term risk of coronary heart disease and cancer in the Seven Countries Study. Arch. Intern. Med., 1995; 155; 381-386.
17. Hertog M.G.L., Sweetnam P.M., Fehily A.M. et al.: Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am. J. Clin. Nutr., 1997; 65; 1489-1494. (Pubitemid 27187762)
18. Hollman P.C.H., Katan M.B.: Dietary flavonoids: intake, health effects and bioavailability. Food Chem. Toxicol., 1999; 37 (9-10); 937-942. (Pubitemid 29481795)
19. Kim H.P., Son K.H., Chang H.W. et al.: Anti-inflammatory plant flavonoids and cellular action mechanisms. J. Pharmacol. Sci., 2004; 96; 229-245. (Pubitemid 40013328)
20. Kim J.M., Yun-Choi H.S.: Anti-platelet effects of flavonoids and fiavonoid- glycosides from Sophora japonica. Arch. Pharm. Res., 2008; 31; 886-890.
21. Knekt P., Jarvinen R., Reunanen A. et al.: Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ, 1996; 312; 478-481. (Pubitemid 26061237)
22. Kuppusamy U.R., Khoo H.E., Das N.P.: Structure-activity studies of flavonoids as inhibitors of hyaluronidase. Biochem Pharmacol., 1990; 40 (2); 397-401. (Pubitemid 20218864)
23. Maeda K., Kuzuya M., Cheng X.W. et al.: Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier. Atherosclerosis, 2002; 166; 23-30.
24. Majewska M., Czeczot H.: Flawonoidy w profilaktyce i terapii. Farm. Pol., 2009; 65 (5); 369-377.
25. Małolepsza U., Urbanek H.: Flawonoidy roślinne jako zwiazki biochemicznie czynne. Wiad. BoŁ. 2000; 44; 27-37.
26. Middleton J.E., Kandaswami C., Theoharides T.C.: The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev., 2000; 52 (4); 673-751.
27. Miller E., Malinowska K., Galecka E. i wsp.: Rola flawonoidów jako przeciwutteniaczy w organizmie człowieka. Pol. Merk. Lek., 2008; XXIV; 144; 556-560.
28. Nijveldt R.J., Nood E., Hoorn D.E.C. et al.: Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr., 2001; 74 (4); 418-425. (Pubitemid 32880250)
29. Olszewska M.: Flawonoidy i ich zastosowanie w lecznictwie. Farm. Pol., 2003; 59 (9); 391-401.
30. Sadik C.D., Sles H., Schewe T.: Inhibition of 15-lipoxygenases by flavonoids: structure -activity relations and mode of action. Biochem. Pharmacol., 2003; 65 (5); 773-781. (Pubitemid 36293694)
31. Serafini M., Ghiselli A., Ferro Luzzi A.: In vivo antioxidant effect of green and black tea in man. Eur. J. Clin. Nutr., 1996; 50; 28-32. (Pubitemid 26033486)
32. Seyoum A., Asres K., Et-Fiky F.K.: Structure-radical scavenging activity relationships of flavonoids. Phytochemistry, 2006; 67; 2058-2070. (Pubitemid 44301284)
33. Son D.J., Cho M.R., Jin Y.R. et al.: Antiplatelet effect of Green tea catechins: a possible mechanism through arachidonic acid pathway. Prostaglandins Leukot. Essent. Fatty Acids, 2004; 71; 25-31.
34. Tapas A.R., Sakarkar D.M., Kakde R.B.: Flavonoids as nutraceuticals: a review. Trop. J. Pharm. Res., 2008; 7 (3); 1089-1099.
35. Valenzuela A., Sanhueza J., Nieto S.: Cholesterol oxidation: health hazard and the role of antioxidants in prevention. Biol. Res., 2003; 36 (3-4); 291-302. (Pubitemid 37427982)
36. Van het Hof K.H., Kivits G.A.A., Weststrate J.A. et al.: Bioavilability ofcatechins from tea: the effect of milk. Eurp. J. Clin. Nutr., 1998; 52; 356-359. (Pubitemid 28230702)
37. Wadsworth T.L., Koop D. R.: Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide - induced release of nitric oxide. Chem. Biol. Interact., 2001; 137 (1); 43-58. (Pubitemid 32772760)
38. Yao L.H., Jiang Y.M., Shi J. et al.: Flavonoids in food and their health benefits. Plant Foods Hum. Nutr., 2004; 59 (3); 113-122. (Pubitemid 40172010)
39. Yochum L., Kushi L.H., Meyer K. et al.: Dietary tlavonoid intake and risk of cardiovascular disease in postmenopausal women. Am. J. Epidemiol., 1999; 149 (10); 943-949. (Pubitemid 29230709)